CBD / Cannabadiol reduces seizures in Dravet Syndrome

Side effects were frequently seen. Your epilepsy specialist should monitor effects on other anticonvulsants. - JR

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Share this content:

• MORE HERE
• twitter
• linkedin
• google
• Comments
• Print

Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.

HOUSTON – Adjunctive treatment with cannabidiol reduces convulsive seizure frequency in patients with Dravet syndrome, according to results from a phase 3 study presented at the 2016 American Epilepsy Society Annual Meeting.

While efficacy has previously been demonstrated in this population in data reported from an expanded-access program, this is the first placebo-controlled trial examining the efficacy and safety of cannabidiol in refractory Dravet syndrome.